Anti-epileptogenic Clinical Trial Designs in Epilepsy: Issues and Options

[1]  J. Maytal,et al.  Febrile Status Epilepticus , 1990, Journal of Pediatric Epilepsy.

[2]  M. Dichter,et al.  Anti-epileptogenic Clinical Trial Designs in Epilepsy: Issues and Options , 2014, Neurotherapeutics.

[3]  Dieter Schmidt,et al.  New avenues for anti-epileptic drug discovery and development , 2013, Nature Reviews Drug Discovery.

[4]  I. Módy,et al.  Issues related to development of antiepileptogenic therapies , 2013, Epilepsia.

[5]  G. Holmes,et al.  Development of new treatment approaches for epilepsy: Unmet needs and opportunities , 2013, Epilepsia.

[6]  G. Holmes,et al.  Issues related to symptomatic and disease‐modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy , 2013, Epilepsia.

[7]  A. Kanner.  The treatment of depressive disorders in epilepsy: What all neurologists should know , 2013, Epilepsia.

[8]  D. Friedman,et al.  Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions , 2012, The Lancet Neurology.

[9]  Shumei S. Sun,et al.  MRI abnormalities following febrile status epilepticus in children , 2012, Neurology.

[10]  D. Schmidt.  Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons , 2012, Epileptic disorders : international epilepsy journal with videotape.

[11]  J D Norrie,et al.  Patterns of treatment response in newly diagnosed epilepsy , 2012, Neurology.

[12]  J. Engel.  Biomarkers in epilepsy: introduction. , 2011, Biomarkers in medicine.

[13]  S. Shinnar,et al.  Prospects for imaging-related biomarkers of human epileptogenesis: a critical review. , 2011, Biomarkers in medicine.

[14]  Hal Blumenfeld,et al.  Neuroimaging biomarkers of epileptogenesis , 2011, Neuroscience Letters.

[15]  M. Dichter,et al.  Human clinical trails in antiepileptogenesis , 2011, Neuroscience Letters.

[16]  Dieter Schmidt,et al.  Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma , 2011, Epilepsia.

[17]  Brian Callaghan,et al.  Remission and relapse in a drug‐resistant epilepsy population followed prospectively , 2011, Epilepsia.

[18]  A. Pitkänen,et al.  Mechanisms of epileptogenesis and potential treatment targets , 2011, The Lancet Neurology.

[19]  Wolfgang Löscher,et al.  Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research , 2010, Pharmacological Reviews.

[20]  R. Duncan.  Faculty Opinions recommendation of Quantifying the response to antiepileptic drugs: effect of past treatment history. , 2010 .

[21]  Gary W. Mathern,et al.  Erratum: Definition of drug resistant epilepsy. Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies (Epilepsia (2010) 51 (1069-77)) , 2010 .

[22]  A. Pitkänen.  Therapeutic approaches to epileptogenesis—Hope on the horizon , 2010, Epilepsia.

[23]  A. Obenaus,et al.  Epileptogenesis Provoked by Prolonged Experimental Febrile Seizures: Mechanisms and Biomarkers , 2010, The Journal of Neuroscience.

[24]  Albert C. Ludolph,et al.  Guidelines for preclinical animal research in ALS/MND: A consensus meeting , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[25]  S. Camposano,et al.  The natural history of epilepsy in tuberous sclerosis complex , 2009, Epilepsia.

[26]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[27]  S. Papapetropoulos.  A Double-Blind, Delayed-Start Trial of Rasagiline In Parkinson's Disease , 2010 .

[28]  M. Bialer,et al.  Key factors in the discovery and development of new antiepileptic drugs , 2010, Nature Reviews Drug Discovery.

[29]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[30]  A. Pitkänen,et al.  From traumatic brain injury to posttraumatic epilepsy: What animal models tell us about the process and treatment options , 2009, Epilepsia.

[31]  N. Temkin.  Preventing and treating posttraumatic seizures: The human experience , 2009, Epilepsia.

[32]  M. Sillanpää,et al.  Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. , 2008, Brain : a journal of neurology.

[33]  D. Gutmann,et al.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.

[34]  D. Redelmeier,et al.  Translation of research evidence from animals to humans. , 2006, JAMA.

[35]  Dieter Schmidt,et al.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. , 2006, Brain : a journal of neurology.

[36]  S. Herman.  Clinical trials for prevention of epileptogenesis , 2006, Epilepsy Research.

[37]  L. Gjerstad,et al.  Poststroke Epilepsy: Occurrence and Predictors—A Long‐term Prospective Controlled Study (Akershus Stroke Study) , 2005, Epilepsia.

[38]  L. Goldstein,et al.  Seizures and Epilepsy After Ischemic Stroke , 2004, Stroke.

[39]  John W. Miller,et al.  Post-traumatic epilepsy following fluid percussion injury in the rat. , 2004, Brain : a journal of neurology.

[40]  W. Hauser,et al.  The Epidemiology of Traumatic Brain Injury: A Review , 2003, Epilepsia.

[41]  P. V. Van Ness,et al.  Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. , 2003, Archives of neurology.

[42]  K. Meador.  Cognitive outcomes and predictive factors in epilepsy , 2002, Neurology.

[43]  N. Temkin.  Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta‐Analysis of Controlled Trials , 2001, Epilepsia.

[44]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[45]  S Shinnar,et al.  Short‐Term Outcomes of Children with Febrile Status Epilepticus , 2001, Epilepsia.

[46]  A. Alexandrov,et al.  Seizures after stroke: a prospective multicenter study. , 2000 .

[47]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[48]  E. Mizrahi,et al.  Neonatal seizures: early-onset seizure syndromes and their consequences for development. , 2000, Mental retardation and developmental disabilities research reviews.

[49]  J. Tyson,et al.  Incidence of neonatal seizures in Harris County, Texas, 1992-1994. , 1999, American journal of epidemiology.

[50]  N R Temkin,et al.  Valproate therapy for prevention of posttraumatic seizures: a randomized trial. , 1999, Journal of neurosurgery.

[51]  H Feldman,et al.  Seizure control and mortality in epilepsy , 1999, Annals of neurology.

[52]  W. Hauser,et al.  Risk of unprovoked seizure after acute symptomatic seizure: Effect of status epilepticus , 1998, Annals of neurology.

[53]  B. A. Boucher,et al.  Pharmacokinetic Alterations After Severe Head Injury , 1998, Clinical pharmacokinetics.

[54]  W. Hauser,et al.  Incidence of status epilepticus in Rochester, Minnesota, 1965-1984 , 1998, Neurology.

[55]  R. Sacco,et al.  Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. , 1998, American journal of epidemiology.

[56]  W. Hauser,et al.  A population-based study of seizures after traumatic brain injuries. , 1998, The New England journal of medicine.

[57]  J. Hahn,et al.  Predictive value of EEG for outcome and epilepsy following neonatal seizures. , 1996, Electroencephalography and clinical neurophysiology.

[58]  J. Osborne,et al.  MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY , 1996, Developmental medicine and child neurology.

[59]  R. Clancy,et al.  Neurologic outcome after electroencephalographically proven neonatal seizures. , 1991, Pediatrics.

[60]  J. Osborne,et al.  On the incidence of fits and mental retardation in tuberous sclerosis. , 1991, Journal of medical genetics.

[61]  H. Winn,et al.  Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. , 1991, JAMA.

[62]  N R Temkin,et al.  A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. , 1990, The New England journal of medicine.

[63]  L. Noble,et al.  Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model , 1989, Neuroscience.

[64]  W. Hauser,et al.  The risk of unprovoked seizures after encephalitis and meningitis , 1988, Neurology.

[65]  W. Hauser,et al.  Factors prognostic of unprovoked seizures after febrile convulsions. , 1987, The New England journal of medicine.

[66]  L. Kurland,et al.  Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982 , 1985, Neurology.

[67]  W. Hauser,et al.  Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950–1981: I. Epidemiology , 1984, Annals of neurology.

[68]  J M Freeman,et al.  Neonatal seizures. I. Correlation of prenatal and perinatal events with outcomes. , 1982, Pediatrics.

[69]  E. Laws,et al.  The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935–1974 , 1980, Neurology.

[70]  F. Talbot.  Treatment of Epilepsy , 1931 .